WHO Dismisses Senior Manager on Sexual Misconduct Charges – British Doctor Expresses ‘Relief’ 24/04/2023 Elaine Ruth Fletcher The World Health Organization (WHO) has dismissed a senior manager at its Geneva Headquarters, Temo Waqanivalu, on charges of sexual misconduct following a six-month investigation into allegations that he harassed a young British doctor at the World Health Summit in Berlin last October. This is the first high-profile dismissal of an official at WHO’s headquarters […] Continue reading -> Sudan Hospital Closures Leave Injured Civilians With Nowhere to Go 21/04/2023 Stefan Anderson As the new moon marking the beginning of Eid festivities rose on Thursday evening, people in the Sudanese capital of Khartoum sheltered from bullets and explosions as prayers that a ceasefire to honour the end of the holy month of Ramandan would take effect went unanswered. At least 400 people have been killed in a […] Continue reading -> How India’s ‘COVID Warriors’ Used Social Media To Serve Their Communities 21/04/2023 Megha Kaveri In mid-2021, India was crumbling under the pressure of an intense COVID-19 wave, caused by the Delta variant of the SARS-CoV-2. But at the same time, misinformation was spreading exponentially – adding to the fear and anxiety of the time. Thousands of people were scrambling to find oxygen cylinders and hospital beds for their […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
Sudan Hospital Closures Leave Injured Civilians With Nowhere to Go 21/04/2023 Stefan Anderson As the new moon marking the beginning of Eid festivities rose on Thursday evening, people in the Sudanese capital of Khartoum sheltered from bullets and explosions as prayers that a ceasefire to honour the end of the holy month of Ramandan would take effect went unanswered. At least 400 people have been killed in a […] Continue reading -> How India’s ‘COVID Warriors’ Used Social Media To Serve Their Communities 21/04/2023 Megha Kaveri In mid-2021, India was crumbling under the pressure of an intense COVID-19 wave, caused by the Delta variant of the SARS-CoV-2. But at the same time, misinformation was spreading exponentially – adding to the fear and anxiety of the time. Thousands of people were scrambling to find oxygen cylinders and hospital beds for their […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
How India’s ‘COVID Warriors’ Used Social Media To Serve Their Communities 21/04/2023 Megha Kaveri In mid-2021, India was crumbling under the pressure of an intense COVID-19 wave, caused by the Delta variant of the SARS-CoV-2. But at the same time, misinformation was spreading exponentially – adding to the fear and anxiety of the time. Thousands of people were scrambling to find oxygen cylinders and hospital beds for their […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts
DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Posts navigation Older postsNewer posts